Sligo 29th June 2015 –Minister for Jobs, Enterprise and Innovation Richard Bruton TD, today announced that AbbVie (ABBV: NYSE) is creating 50 jobs and investing €40 million in expanding its development and manufacturing capacity at its Ballytivnan site in Sligo over the next four years. This is in addition to 75 jobs created at the site since AbbVie was launched in 2013.
The investment is supported by the Department of Jobs, Enterprise and Innovation through IDA Ireland.
The company’s manufacturing site in Ballytivnan currently produces drug delivery devices, including a pen-style injector which is used by patients worldwide receiving an AbbVie treatment indicated for a range of auto-immune conditions.
AbbVie has a strong pipeline of specialty drugs and formulations, and the Ballytivnan site is poised to develop and manufacture a range of new medical delivery devices with this investment. The investment includes building expansion, facility upgrade and remodelling, and new manufacturing equipment to increase AbbVie’s drug delivery device capabilities